Darshana Zaveri

Darshana is a Founder and Managing Partner of CHV. She is actively involved in all aspects of fund management, including investments and capital raising in the medical device, women’s health, and diagnostics markets. She led CHV 1 investments in Augmenix (acquired by Boston Scientific), nVision Medical (acquired by Boston Scientific), and Aria CV. Prior to joining CHV in 2007, Darshana was an Investigator at Vertex Pharmaceuticals, and an integral part of drug development programs in oncology, metabolic disease, and immunology. She also has experience in biotechnology and completed an internship at the United Nations. She has authored several publications and scientific journal articles. Darshana currently serves on the Board of several medical device companies, including Avive’s, and is an advisor for various foundations and investment funds. Darshana received an M.P.A. from Harvard University, an M.A. in Cell and Molecular Biology from Boston University, and a B.S. in Biochemistry from Bombay University in Bombay, India.